Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2025-03-12 00:00:00 ET · period of report 2025-03-10 · accession 0001415889-25-007791 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-12 | 2025-03-10 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas, Dir | A - Grant | $0.00 | +36.7K | 130.2K | +39% | $0 |
| D | 2025-03-12 | 2025-03-10 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas, Dir | A - Grant | $0.00 | +78.0K | 78.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-10 | A | A | 36,747 | $0.00 | 130,230 | D | — | — | (F1) The reported shares are represented by restricted stock units, or RSUs, which vest in four equal annual installments beginning on March 10, 2026. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2025-03-10 | A | A | 78,039 | $0.00 | 78,039 | D | $28.41 · — to 2035-03-10 | 78,039 Common Stock | (F2) The shares subject to the option vest in four equal annual installments beginning on March 10, 2026. |